FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321373883> ?p ?o ?g. }

• W4321373883 abstract "Abstract Background Obex® may be helpful in reducing body weight and fat. The current study was carried out to evaluate the efficacy and safety of Obex® in the treatment of overweight and obese subjects. Methods A double-blind, randomised, controlled phase III clinical trial was conducted involving 160 overweight and obese subjects (BMI ≥ 25.0 and < 40 kg/m 2 ) aged 20 to 60 years, who received Obex® ( n = 80) and placebo ( n = 80) plus non-pharmacological treatment (physical activity and nutritional counseling). One sachet of Obex® or placebo were administered before the two main meals each day for 6 months. In addition to anthropometric measurements and blood pressure, fasting plasma and 2 h glucose levels during the oral glucose tolerance test, lipid profile, insulin, liver enzymes, creatinine, and uric acid (UA) were determined, insulin resistance (HOMA-IR) beta-cell function (HOMA-β) were assessed and insulin sensitivity (IS) was calculated with three indirect indexes. Results After 3 months of Obex®, 48.3% of the participants (28/58) achieved complete success in reducing both weight and waist circumference by greater than or equal to 5% from baseline, as opposed to 26.0% (13/50) of individuals receiving placebo ( p = 0.022). Compared to baseline, at 6 months no differences were found between the groups concerning anthropometric and biochemical measurements, except for high-density lipoprotein cholesterol (HDL-c) levels, which were higher in subjects receiving Obex® compared to those receiving placebo ( p = 0.030). After 6 months of treatment, both groups showed reduced cholesterol and triglyceride levels ( p < 0.012) compared to baseline value. However, only those intake Obex® showed reduced insulin concentrations and HOMA-IR, improved IS ( p < 0.05), and decreased creatinine and UA levels ( p < 0.005). Conclusions The consumption of Obex® together with lifestyle changes increased HDL-c, contributed to a rapid reduction of weight and waist circumference, as well as improved insulin homeostasis, which did not occur in the placebo group, and appears to be safe as an adjunct at conventional obesity treatment. Trial registration Clinical trial protocol was registered in the Cuban public registry of clinical trials under code RPCEC00000267 on 17/04/2018 and also registered in the international registry of clinical trials, ClinicalTrials.gov, under code: NCT03541005 on 30/05/2018." @default.
• W4321373883 created "2023-02-21" @default.
• W4321373883 creator A5003993942 @default.
• W4321373883 creator A5011544306 @default.
• W4321373883 creator A5016580059 @default.
• W4321373883 creator A5018192611 @default.
• W4321373883 creator A5025140698 @default.
• W4321373883 creator A5028756369 @default.
• W4321373883 creator A5028955618 @default.
• W4321373883 creator A5035399273 @default.
• W4321373883 creator A5038399231 @default.
• W4321373883 creator A5045906876 @default.
• W4321373883 creator A5060370409 @default.
• W4321373883 creator A5063211871 @default.
• W4321373883 creator A5067080381 @default.
• W4321373883 creator A5067972228 @default.
• W4321373883 creator A5079381676 @default.
• W4321373883 creator A5085139561 @default.
• W4321373883 creator A5088974956 @default.
• W4321373883 creator A5013069069 @default.
• W4321373883 date "2023-02-20" @default.
• W4321373883 modified "2023-10-16" @default.
• W4321373883 title "Efficacy and safety of Obex® in overweight and obese subjects: a randomised, double-blind, placebo-controlled clinical trial" @default.
• W4321373883 cites W1704716481 @default.
• W4321373883 cites W1974998390 @default.
• W4321373883 cites W1996590762 @default.
• W4321373883 cites W2009232925 @default.
• W4321373883 cites W2011434508 @default.
• W4321373883 cites W2027908094 @default.
• W4321373883 cites W2029465266 @default.
• W4321373883 cites W2044206013 @default.
• W4321373883 cites W2046120374 @default.
• W4321373883 cites W2070260892 @default.
• W4321373883 cites W2078630806 @default.
• W4321373883 cites W2094060207 @default.
• W4321373883 cites W2095284945 @default.
• W4321373883 cites W2107598199 @default.
• W4321373883 cites W2113828225 @default.
• W4321373883 cites W2118404525 @default.
• W4321373883 cites W2122367003 @default.
• W4321373883 cites W2123931921 @default.
• W4321373883 cites W2127147300 @default.
• W4321373883 cites W2127458301 @default.
• W4321373883 cites W2160234571 @default.
• W4321373883 cites W2167880362 @default.
• W4321373883 cites W2169248481 @default.
• W4321373883 cites W2171129594 @default.
• W4321373883 cites W2267969507 @default.
• W4321373883 cites W2503465052 @default.
• W4321373883 cites W2534293284 @default.
• W4321373883 cites W2548768578 @default.
• W4321373883 cites W2605038697 @default.
• W4321373883 cites W2606165087 @default.
• W4321373883 cites W2607031541 @default.
• W4321373883 cites W2735164863 @default.
• W4321373883 cites W2735376054 @default.
• W4321373883 cites W2737575381 @default.
• W4321373883 cites W2766795193 @default.
• W4321373883 cites W2766841052 @default.
• W4321373883 cites W2790337982 @default.
• W4321373883 cites W2791927263 @default.
• W4321373883 cites W2885588864 @default.
• W4321373883 cites W2889034659 @default.
• W4321373883 cites W2893361247 @default.
• W4321373883 cites W2900922115 @default.
• W4321373883 cites W2910952524 @default.
• W4321373883 cites W2921943094 @default.
• W4321373883 cites W2935715550 @default.
• W4321373883 cites W2947792400 @default.
• W4321373883 cites W2957331604 @default.
• W4321373883 cites W2970916347 @default.
• W4321373883 cites W2984149348 @default.
• W4321373883 cites W2994609197 @default.
• W4321373883 cites W2998401118 @default.
• W4321373883 cites W3013603206 @default.
• W4321373883 cites W3023930125 @default.
• W4321373883 cites W3028550582 @default.
• W4321373883 cites W3029109953 @default.
• W4321373883 cites W3085724896 @default.
• W4321373883 cites W3087426375 @default.
• W4321373883 cites W3092203240 @default.
• W4321373883 cites W3096535522 @default.
• W4321373883 cites W3135683691 @default.
• W4321373883 cites W3136528886 @default.
• W4321373883 cites W3137678292 @default.
• W4321373883 cites W3139183097 @default.
• W4321373883 cites W3172220467 @default.
• W4321373883 cites W3175360642 @default.
• W4321373883 cites W3180130918 @default.
• W4321373883 cites W3201356800 @default.
• W4321373883 cites W3208814196 @default.
• W4321373883 cites W3214272568 @default.
• W4321373883 cites W3217337816 @default.
• W4321373883 cites W4200270203 @default.
• W4321373883 cites W4283207551 @default.
• W4321373883 cites W4291001688 @default.
• W4321373883 cites W807162506 @default.
• W4321373883 cites W963575413 @default.
• W4321373883 doi "https://doi.org/10.1186/s12906-023-03847-7" @default.
• W4321373883 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36804035" @default.

• next